We are pleased to announce that the digital 3rd Annual European HealthTech CEO Forum(EHTF), will take place on the 28th of February 2022 and will be part of the Sachs Spring Life Sciences Week (SSLSW). The latter will also incorporate the 15th Annual European Life Sciences CEO Forum. This will allow us to further support our community and past attendees. We will provide both the usual stimulating program and networking opportunities through our online video and audio meeting system.
The 3rd Annual EHTF will take place on the 28th of February and will focus oninvestment & partnership in MedTech and Digital Health. The programme will feature topical keynotes and panels with industry leaders as well as around 20 corporate presentations by public, private and growth companies. We anticipate 200+ delegates, including major and growth corporates, financial investors/partners, bankers and advisors.
Virtual meetings will take place on the 28th of February to 4th of March. Moreover, the system will be open for 12 hours a day, and we expect 1000+ meetings completed during SSLSW. The conference will be held in the Central European Time Zone. The digital event will consist of:
HealthTech Innovation Day (Monday, 28th of February)
Pharma: Accelerating Digital Innovation Panel
Investing in Digital Health & Therapeutics Panel
European MedTech & Device Panel
Innovation & Early Stage Investment Panel
European Health Tech Startups Presented by EIT Health
Confirmed Keynote Speakers Include:
Eyal Zimlichman, Deputy Director General, CMO & CIO, Sheba Medical Center
Kurt Höller, Director of Business Creation, EIT Health e.V.
Raphaël Conz, Economic Promotion Manager, Office for Economic Affairs and Innovation (SPEI)
Rana Lonnen, Managing Director, Novartis Pharma AG
Regina Hodits, Managing Partner, Wellington Partners Life Sciences (WPLS)
Samuel Levy, Founding Partner, Lauxera Capital Partners
Shy Zyman, Partner, Cukierman & Co. Life Sciences
Tamir Meiri, Director, Venture Investments, Johnson & Johnson Innovation – JJDC, Inc.*
Tanja Dowe, CEO, Debiopharm Innovation Fund SA
Thijs Cohen Tervaert, Junior Partner, INKEF Capital BV
Wilder Fulford, Founder & Managing Director, The Fulford Group Ltd.
Yaron Daniely, Partner at aMoon & the Head of aMoon Alpha
PARTICIPATION OPTIONS INCLUDE:
Basic Online Meeting System Access with 10 meeting invitations will be provided complimentary for qualified institutional (buy/sell-side), private equity and venture investors. The number of passes are limited, and priority is given to regular participants, however the organiser has the discretion to reject passes. Other participants may consider purchasing Basic, Advanced or Premium Access with an option for a live spotlight or a pre-recorded showcase presentation.
The Online Meeting System will open on the 14th of February for uploading profiles and sending meeting invites. Virtual meetings will take place from the 28th February to 4th of March. This system will allow you to have a secure audio/video call, as well as an option to present slides using the screen share function. Meetings will last for 30 minutes. The number of meeting invites defines how many requests can be sent. If the meeting invite is declined, you will receive an invite credit back that can be reused. The number of invites does not restrict how many meeting invitations you can receive.
Alternatively, free access to view live sessions is provided to interested and qualified participants (except service providers). This will allow us to increase the size of the audience and provide a higher exposure for participating companies. Additionally, you can purchase a Video on Demand pass, which will allow you to view not only live sessions, but also recordings of all sessions, in addition to speaker and company profiles and their presentations.
Gain additional exposure to high-level decision makers by presenting at the forum, which offers excellent opportunities to showcase your company’s investment and partnering offering. This typically includes technology and financial highlights. This adds to the news flow from the forum and generates greater interest in meetings from other delegates. For those interested to join the companies’ showcases, there is an option to purchase either a 10 or 20-minute presentation, which will be pre-recorded in advance and available to all registered attendees before, during and after the conference on the event’s portal. There are also a limited number of 20-min Spotlight presentations with additional branding to provide even higher exposure, which will be broadcasted live during the main programme after relevant panel discussion and available on demand afterwards. Start-up companies, which are looking for seed financing may also apply for a 5 or 10 minute showcase option. The Sachs team can assist with the pre-recording of the presentation or you can upload a video you already have. Interested viewers will be able to message or request a meeting with you using the Online Meeting System.
Make connections, engage in conversation, and exchange knowledge with key decision-makers eager to learn how your company can help them meet their goals and achieve their mission. Exhibiting at Sachs Spring Life Sciences Week is an effective way to gain leads, introduce new products and services, expand sales, and build relationships.
The virtual exhibition package includes a dedicated virtual page, where we can: upload your branded company’s profile and list ways to reach you; share video or images about services you provide; have files ready for download, if you wish to share any additional information with potential clients.
There are a limited number of sponsorship opportunities for the forum, which includes speaking, advertising and branding options. Sponsors typically include investment banks and funds, large pharma, technology companies and service providers, including Stock Exchanges, IR companies, CROs, international lawyers and consulting companies. Tailored packages are available upon request. You can view latest event’s sponsors here.
Investors & Analysts Attending:
3B Future Health Ventures Abingworth LLP AdBio Partners Additio Investment Group Aescuvest International Alon MedTech Ventures Alpha Blue Ocean Ltd. Amadeus Capital Partners aMoon Fund Apeiron Investments Apollo Health Ventures Aqua Partners LLC ARCH Venture Partners Asabys Partners Asklepios Advisors ATGN Consulting BCG Digital Ventures Bergmann zur Hausen & Cie. GmbH BERNINA BioInvest Ltd. BIMA Capital, LLC Bio Medi Gene Ventures BIOSTART Consulting GmbH BioValley Basel & Suterscience, LLC BioVeda China Fund (BVCF) bmp Ventures AG Bootstrap Europe SCSP Bradley Woods & Co. Ltd Brightlands Venture Partners Brookline Capital Markets BROTHERS & Partners Europe Capricorn Partners Catalytic Impact Foundation, Inc. Cello Health BioConsulting Clave Mayor S.G.E.I.C., S.A. coparion GmbH & Co. KG Cukierman & Co. Life Sciences Debiopharm Innovation Fund SA Deutsche Bank Digital Networks PLC E.Gutzwiller & Cie, Banquiers Eight Roads Ventures ESC Advisors Ferghana Partners LLP Fraser Finance LLP FutuRx Ltd. GCF Family Office GEM Generation Fund Life Sciences Fund I Gilde Healthcare Partners Gimv NV Global Founders Capital Global Health Investment Corporation GLSV GmbH iL | MicroCures Inc | Neurevo GmbH Hadean Ventures High-Tech Gründerfonds Management GmbH IAG - Italian Angels for Growth IAG, Image Analysis Group IBB Beteiligungsgesellschaft GmbH ICF Consult Switzerland Ignite Capital Partners, Inc. Illumina Ventures Indaco Venture Partners SGR SpA Independent R.B. Independent R.M. Industrifonden INKEF Capital BV Inveready Asset Management IPF Partners